TRANSFORM - Observational Cohort Study of Aranesp Use in EU Haemodialysis Patients Switched From Mircera

Trial Profile

TRANSFORM - Observational Cohort Study of Aranesp Use in EU Haemodialysis Patients Switched From Mircera

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2014

At a glance

  • Drugs Darbepoetin alfa (Primary) ; Methoxy polyethylene glycol-epoetin beta
  • Indications Anaemia
  • Focus Therapeutic Use
  • Acronyms TRANSFORM
  • Sponsors Amgen
  • Most Recent Events

    • 05 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top